Notably, we found that increased GDNF levels have a protective effect in supranigrally delivered lactacystin model of Parkinson’s disease; this effect is not mediated by protecting DA cell bodies in the substantia nigra pars compacta, but by enhancing the dopaminergic function in the striatum. The gene discussed is GDNF; the disease is Parkinson disease.